<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04929795</url>
  </required_header>
  <id_info>
    <org_study_id>HSEARS20210610001</org_study_id>
    <nct_id>NCT04929795</nct_id>
  </id_info>
  <brief_title>Effects of Music Beat on Motor Function in Individuals at Risk for Psychotic Onset and Schizophrenia Patients</brief_title>
  <official_title>Effects of Music Beat on Motor Function in Individuals at Risk for Psychotic Onset and Schizophrenia Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr WANG Shumei</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Hong Kong Polytechnic University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this project is to investigate whether a 3-week training program involving&#xD;
      music beat (serving as a type of rhythmic auditory stimulation) reduces the severity of&#xD;
      bradykinesia and dyskinesia in at-risk individuals and schizophrenia patients. It is&#xD;
      hypothesized that the program is effective in reducing the severity of bradykinesia and&#xD;
      dyskinesia in at-risk individuals and schizophrenia patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 11, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Motion analysis by using an eight-camera motion capture system (VICON; Oxford Metrics Group, Oxford, UK)</measure>
    <time_frame>Within one week right before the 1st session of the intervention</time_frame>
    <description>normalized movement time (representing severity of bradykinesia). Unit: second/mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Motion analysis by using an eight-camera motion capture system (VICON; Oxford Metrics Group, Oxford, UK)</measure>
    <time_frame>Within one week right after the last session of the intervention</time_frame>
    <description>normalized movement time (representing severity of bradykinesia). Unit: second/mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Motion analysis by using an eight-camera motion capture system (VICON; Oxford Metrics Group, Oxford, UK)</measure>
    <time_frame>Within one week right before the 1st session of the intervention</time_frame>
    <description>normalized number of movement units (representing severity of dyskinesia). Unit: units/mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Motion analysis by using an eight-camera motion capture system (VICON; Oxford Metrics Group, Oxford, UK)</measure>
    <time_frame>Within one week right after the last session of the intervention</time_frame>
    <description>normalized number of movement units (representing severity of dyskinesia). Unit: units/mm</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Schizophrenia</condition>
  <condition>Psychosis</condition>
  <condition>Parkinsonism</condition>
  <condition>Dyskinesias</condition>
  <arm_group>
    <arm_group_label>at risk- RAS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>At-risk individuals in the experimental group will undergo upper-limb movement training with the aid of music beat serving as a type of rhythmic auditory stimulation (RAS).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>at risk- no RAS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>At-risk individuals in the control group will receive upper-limb training without the aid of RAS.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>schizophrenia- RAS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Schizophrenia patients in the experimental group will undergo upper-limb movement training with the aid of RAS.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>schizophrenia- no RAS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Schizophrenia patients in the control group will receive upper-limb training without the aid of RAS.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Rhythmic auditory stimulation (RAS)</intervention_name>
    <description>The song named 'Sign of The Times' is played and recorded by the research personnel beforehand. The beat of the song will serve as RAS. The computer software &quot;Audacity&quot; will be used to adjust tempi of RAS. Before intervention, the participant is required to execute the movement task without the aid of RAS as quickly as possible for 30 seconds, so that we obtain his/her baseline movement tempo. For each 40-minute training session in the first training week, three RAS tempi will be provided for the first, second, and last 10 minutes with a five-minute break in between: normal (100% of the baseline tempo), quick (105% of the baseline tempo), and fast (110% of the baseline tempo). With each training week, the three RAS tempi will be increased by 5%. Participants in the experimental groups are required to use their right hand to pick up beads from source bowls to the target bowl when listening to the song. The 3-week intervention program will include 21 40-minute daily training sessions.</description>
    <arm_group_label>at risk- RAS</arm_group_label>
    <arm_group_label>schizophrenia- RAS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>no RAS</intervention_name>
    <description>The training protocol will be the same as that used in the experimental group except the lack of RAS during execution of the movement task.</description>
    <arm_group_label>at risk- no RAS</arm_group_label>
    <arm_group_label>schizophrenia- no RAS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        For at-risk participants:&#xD;
&#xD;
        Inclusion criteria:&#xD;
&#xD;
          1. A score of or above 9 in the Chinese version of the 16-item Prodromal Questionnaire&#xD;
             (CPQ-16), or a score of or above 8.18 in the Chinese version of Community Assessment&#xD;
             of Psychic Experiences with 15 items (CAPE-C15), or a score of or above 17 in&#xD;
             Schizotypal Personality Questionnaire-Brief (SPQ-B);&#xD;
&#xD;
          2. the age between 15-24 years;&#xD;
&#xD;
          3. score &gt; 60 in The Chinese version of Edinburgh Handedness Inventory (CH-EBI) to ensure&#xD;
             right handedness; and&#xD;
&#xD;
          4. score ≥ 22 in Montreal Cognitive Assessment Hong Kong Version (HK-MoCA) to ensure no&#xD;
             serious cognitive deficits so that they can understand instructions.&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          1. psychiatric diagnosis by self-report;&#xD;
&#xD;
          2. cardiovascular, neurological, muscular or orthopedic diseases that may affect hand&#xD;
             movements;&#xD;
&#xD;
          3. taking psychiatric medications;&#xD;
&#xD;
          4. substance abuse; and&#xD;
&#xD;
          5. being pregnant.&#xD;
&#xD;
        For schizophrenia participants:&#xD;
&#xD;
        Inclusion criteria:&#xD;
&#xD;
          1. a diagnosis of schizophrenia without other psychiatric diseases;&#xD;
&#xD;
          2. the age ≥ 18 years;&#xD;
&#xD;
          3. score &gt; 60 in CH-EBI to ensure right handedness; and&#xD;
&#xD;
          4. score ≥ 22 in HK-MoCA to ensure no serious cognitive deficits so that they can&#xD;
             understand instructions.&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          1. cardiovascular, neurological, muscular or orthopedic diseases that may affect hand&#xD;
             movements;&#xD;
&#xD;
          2. substance abuse; and&#xD;
&#xD;
          3. being pregnant.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Shu-Mei Wang, PhD</last_name>
    <phone>852-27664197</phone>
    <email>shumei.wang@polyu.edu.hk</email>
  </overall_contact>
  <location>
    <facility>
      <name>ST814, the Hong Kong Polytechnic University</name>
      <address>
        <city>Kowloon</city>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shu-Mei Wang, PhD</last_name>
      <phone>+852 27664197</phone>
      <email>shumei.wang@polyu.edu.hk</email>
    </contact>
  </location>
  <location_countries>
    <country>Hong Kong</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>June 10, 2021</study_first_submitted>
  <study_first_submitted_qc>June 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 18, 2021</study_first_posted>
  <last_update_submitted>August 12, 2021</last_update_submitted>
  <last_update_submitted_qc>August 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>The Hong Kong Polytechnic University</investigator_affiliation>
    <investigator_full_name>Dr WANG Shumei</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dyskinesias</mesh_term>
    <mesh_term>Parkinsonian Disorders</mesh_term>
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

